메뉴 건너뛰기




Volumn 124, Issue 24, 2011, Pages 2649-2660

Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: The ALPHEE study

(692)  Kowey, Peter R a,b   Crijns, Harry J G M c   Aliot, Etienne M d   Capucci, Alessandro e   Kulakowski, Piotr f   Radzik, David g   Roy, Denis h   Connolly, Stuart J i   Hohnloser, Stefan H j   Singh, B M k   Seltzer, J k   Knight, B P k   Kadish, A H k   Smith, A k   Blaauw, J k   Van Opstal, J k   Vernooy, K k   Van Empel, V k   Smid Ter Bekke, R k   Guedon, L k   more..

g SANOFI   (France)

Author keywords

celivarone; implanted cardioverter defibrillators; sudden death; ventricular arrhythmia

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CELIVARONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO;

EID: 83455205977     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.072561     Document Type: Article
Times cited : (38)

References (16)
  • 1
    • 0028141623 scopus 로고
    • Interpretation of the results of the electrophysiologic study versus electrocardiographic monitoring (ESVEM) study: Programmed ventricular stimulation advocates' view
    • Mitchell LB, Wyse DG. Interpretation of the results of the Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) study: programmed ventricular stimulation advocates view. Coron Artery Dis. 1994;5:671-676. (Pubitemid 24302190)
    • (1994) Coronary Artery Disease , vol.5 , Issue.8 , pp. 671-676
    • Mitchell, L.B.1    Wyse, D.G.2
  • 2
    • 0031057126 scopus 로고    scopus 로고
    • Clinical trials of antiarrhythmic drugs in patients with sustained ventricular tachyarrhthymias
    • Mitchell LB. Clinical trials of antiarrhythmic drugs in patients with sustained ventricular tachyarrhythmias. Curr Opin Cardiol. 1997;12: 33-40. (Pubitemid 27116915)
    • (1997) Current Opinion in Cardiology , vol.12 , Issue.1 , pp. 33-40
    • Mitchell, L.B.1
  • 3
    • 77953008410 scopus 로고    scopus 로고
    • Antiarrhythmic and nonantiarrhythmic drugs for sudden cardiac death prevention
    • Das MK, Zipes DP. Antiarrhythmic and nonantiarrhythmic drugs for sudden cardiac death prevention. J Cardiovasc Pharmacol. 2010;55: 438-449.
    • (2010) J Cardiovasc Pharmacol , vol.55 , pp. 438-449
    • Das, M.K.1    Zipes, D.P.2
  • 5
    • 20844455272 scopus 로고    scopus 로고
    • Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator
    • DOI 10.1161/01.CIR.0000149240.98971.A8
    • Dorian P, Borggrefe M, Al-Khalidi HR, Hohnloser SH, Brum JM, Tatla DS, Brachmann J, Myerburg RJ, Cannom DS, van der Laan M, Holroyde MJ, Singer I, Pratt CM; SHock Inhibition Evaluation with azimiLiDe (SHIELD) Investigators. Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator. Circulation. 2004;110: 3646-3654. (Pubitemid 39665252)
    • (2004) Circulation , vol.110 , Issue.24 , pp. 3646-3654
    • Dorian, P.1    Borggrefe, M.2    Al-Khalidi, H.R.3    Hohnloser, S.H.4    Brum, J.M.5    Tatla, D.S.6    Brachmann, J.7    Myerburg, R.J.8    Cannom, D.S.9    Van Der Laan, M.10    Holroyde, M.J.11    Singer, I.12    Pratt, C.M.13
  • 6
    • 77951960223 scopus 로고    scopus 로고
    • Role of antiarrhythmic drugs in patients with implantable cardioverter defibrillators
    • Van Herendael H, Pinter A, Ahmad K, Korley V, Mangat I, Dorian P. Role of antiarrhythmic drugs in patients with implantable cardioverter defibrillators. Europace. 2010;12:618-625.
    • (2010) Europace , vol.12 , pp. 618-625
    • Van Herendael, H.1    Pinter, A.2    Ahmad, K.3    Korley, V.4    Mangat, I.5    Dorian, P.6
  • 8
    • 79952054595 scopus 로고    scopus 로고
    • Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia
    • Van Herendael H, Dorian P. Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia. Vasc Health Risk Manag. 2010;6:465-472.
    • (2010) Vasc Health Risk Manag , vol.6 , pp. 465-472
    • Van Herendael, H.1    Dorian, P.2
  • 10
    • 3242776199 scopus 로고    scopus 로고
    • In vivo and in vitro characterization of the novel antiarrhythmic agent SSR149744C: Electrophysiological, anti-adrenergic, and anti-angiotensin II effects
    • DOI 10.1097/00005344-200408000-00015
    • Gautier P, Guillemare E, Dijandjighian L, Marion A, Planchenault J, Bernhart C, Herbert JM, Nisato D. In vivo and in vitro characterization of the novel antiarrhythmic agent SSR149744C: electrophysiological, antiadrenergic, and anti-angiotensin II effects. J Cardiovasc Pharmacol. 2004;44:244-257. (Pubitemid 38982169)
    • (2004) Journal of Cardiovascular Pharmacology , vol.44 , Issue.2 , pp. 244-257
    • Gautier, P.1    Guillemare, E.2    Djandjighian, L.3    Marion, A.4    Planchenault, J.5    Bernhart, C.6    Herbert, J.-M.7    Nisato, D.8
  • 13
    • 85080458168 scopus 로고    scopus 로고
    • Double blind placebo COntrolled Dose ranging study of the efficacy and safety of SSR149744c 300 or 600 mg for the conversion of atrial fibrillation/fluttEr (CORYFEE)
    • Accessed October 3, 2011
    • Double Blind Placebo COntrolled Dose Ranging studY of the eFficacy and safEty of SSR149744c 300 or 600 mg for the Conversion of Atrial Fibrillation/fluttEr (CORYFEE). Clinical Trials Web site. http://www. clinicaltrials.gov/ct2/show/NCT00232310?term-CORYFEE&rank-1. Accessed October 3, 2011.
    • Clinical Trials Web Site
  • 14
    • 85080394081 scopus 로고    scopus 로고
    • Celivarone in patients with an implantable cardioverter-defibrillator (ICD): Adjunctive therapy for the reduction of ventricular arrhythmia-triggered ICD interventions
    • published online ahead of print Oct 3
    • Gojkovic O, Aliot EM, Capucci A, Connolly SJ, Crijns H, Hohnloser SH, Kulakowski P, Roy D, Radzik D, Singh BN, Kowey PR. Celivarone in patients with an implantable cardioverter-defibrillator (ICD): adjunctive therapy for the reduction of ventricular arrhythmia-triggered ICD interventions [published online ahead of print Oct 3, 2011]. Heart Rhythm.
    • (2011) Heart Rhythm
    • Gojkovic, O.1    Aliot, E.M.2    Capucci, A.3    Connolly, S.J.4    Crijns, H.5    Hohnloser, S.H.6    Kulakowski, P.7    Roy, D.8    Radzik, D.9    Singh, B.N.10    Kowey, P.R.11


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.